ExploreWatchlistsPricing
  1. JP-listed companies
  2. ZERIA PHARMCEUTICAL CO., LTD.
  3. Financials
  4. Cost of revenue

ZERIA PHARMCEUTICAL CO., LTD. (4559)

Market cap
¥124.2B
P/E ratio
10.3x
Japanese pharmaceutical company that develops and sells prescription drugs, over-the-counter medications, and health products through multiple subsidiaries worldwide.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCost of revenue (Million JPY)YoY (%)
Mar 31, 202623,977+2.68%
Mar 31, 202523,351+15.47%
Mar 31, 202420,224+7.03%
Mar 31, 202318,895+8.69%
Mar 31, 202217,385+10.05%
Mar 31, 202115,797-5.09%
Mar 31, 202016,644-6.25%
Mar 31, 201917,753-3.21%
Mar 31, 201818,342+0.95%
Mar 31, 201718,169+1.33%
Mar 31, 201617,930-3.19%
Mar 31, 201518,521

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat